Trump vs. big pharma

3:19 PM ET Wed, 11 Jan 2017

Chris Meekins, FBR Capital Markets research analyst, and Seamus Fernandez, Leerink Partners managing director & pharma analyst, discuss President-elect Trump's comments on drug pricing and their effect on biotech and pharma stocks.